Zhejiang Biosan Biotechnology

Zhejiang Biosan Biotechnology is a prominent Chinese healthcare company dedicated to the field of birth defect prevention and maternal-child health. Founded in 2003 and headquartered in Hangzhou, the company provides an integrated solution encompassing screening, diagnosis, and personalized treatment support for genetic disorders. Their core business includes the development and manufacturing of in vitro diagnostic (IVD) kits for neonatal and prenatal screening, as well as providing comprehensive laboratory services. Biosan's product portfolio covers a wide range of conditions, including phenylketonuria, congenital hypothyroidism, and chromosomal abnormalities. By leveraging technologies such as tandem mass spectrometry and next-generation sequencing, the company has established itself as a leader in the Chinese precision medicine market.